Search research articles
Contact Us
Filters
Showing results (191-200 of 202) with videos related to
Page
of 21
Sort By:
In Vivo (Athens, Greece)
|
July 2, 2020
Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, et al.
Cancers
|
May 25, 2024
Precision Oncology: Circulating Microvesicles as New Biomarkers in a Very Early Stage of Colorectal Cancer
Anastasios G Kriebardis, Leonidas Chardalias, Christos Damaskos, et al.
Journal of Personalized Medicine
|
April 3, 2021
Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, et al.
Cancers
|
May 16, 2023
The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
Iason Psilopatis, Nikolaos Garmpis, Anna Garmpi, et al.
Journal of Personalized Medicine
|
May 28, 2022
The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, et al.
Anticancer Research
|
December 8, 2020
Animal Models for the Calculation of Circulating Tumor Cells for Experimental Demonstration
Nikolaos Garmpis, Christos Damaskos, Anastasios Angelou, et al.
In Vivo (Athens, Greece)
|
March 4, 2022
Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?
Nikolaos Garmpis, Christos Damaskos, Dimitrios Dimitroulis, et al.
Journal of Personalized Medicine
|
August 6, 2021
Investigational Drug Treatments for Triple-Negative Breast Cancer
Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, et al.
In Vivo (Athens, Greece)
|
January 6, 2021
Inflammatory Fibroid Polyp of the Gastrointestinal Tract: A Systematic Review for a Benign Tumor
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 26, 2018
Histone deacetylase inhibitors as a new anticancer option: How far can we go with expectations? delivery systems
Anna Garmpi, Nikolaos Garmpis, Christos Damaskos, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 202) with videos related to
Sort By:
Page
of 21
In Vivo (Athens, Greece)
|
July 2, 2020
Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, et al.
Cancers
|
May 25, 2024
Precision Oncology: Circulating Microvesicles as New Biomarkers in a Very Early Stage of Colorectal Cancer
Anastasios G Kriebardis, Leonidas Chardalias, Christos Damaskos, et al.
Journal of Personalized Medicine
|
April 3, 2021
Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, et al.
Cancers
|
May 16, 2023
The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
Iason Psilopatis, Nikolaos Garmpis, Anna Garmpi, et al.
Journal of Personalized Medicine
|
May 28, 2022
The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, et al.
Anticancer Research
|
December 8, 2020
Animal Models for the Calculation of Circulating Tumor Cells for Experimental Demonstration
Nikolaos Garmpis, Christos Damaskos, Anastasios Angelou, et al.
In Vivo (Athens, Greece)
|
March 4, 2022
Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?
Nikolaos Garmpis, Christos Damaskos, Dimitrios Dimitroulis, et al.
Journal of Personalized Medicine
|
August 6, 2021
Investigational Drug Treatments for Triple-Negative Breast Cancer
Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, et al.
In Vivo (Athens, Greece)
|
January 6, 2021
Inflammatory Fibroid Polyp of the Gastrointestinal Tract: A Systematic Review for a Benign Tumor
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 26, 2018
Histone deacetylase inhibitors as a new anticancer option: How far can we go with expectations? delivery systems
Anna Garmpi, Nikolaos Garmpis, Christos Damaskos, et al.
Page
of 21